About MagicMed Industries
MagicMed Industries is a biotechnology company that aims to develop psychedelic-derived medicines for the treatment of neurological and psychological indications. On May 24, 2021, MagicMed Industries was acquired by Enveric Biosciences. The terms of the transaction were not disclosed.
Missing: MagicMed Industries's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: MagicMed Industries's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing MagicMed Industries
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
MagicMed Industries is included in 1 Expert Collection, including Psychedelics.
Latest MagicMed Industries News
Oct 20, 2021
Haynes and Boone represented Enveric Biosciences in the transaction. Enveric Biosciences (NASDAQ: ENVB) executed its acquisition of MagicMed Industries Inc., a privately-held biotechnology company focused on […]
MagicMed Industries Frequently Asked Questions (FAQ)
When was MagicMed Industries founded?
MagicMed Industries was founded in 2020.
Where is MagicMed Industries's headquarters?
MagicMed Industries's headquarters is located at 3655 – 36 Street NW, Calgary.
What is MagicMed Industries's latest funding round?
MagicMed Industries's latest funding round is Acquired.
Who are the investors of MagicMed Industries?
Investors of MagicMed Industries include Enveric Biosciences.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.